DRCNet Response to the
Drug Enforcement Administration
Methcathinone is one of the more recent drugs of abuse in the United States and was placed into Schedule I of the CSA in 1993. Known on the streets as "Cat," it is a structural analogue of methamphetamine and cathinone. Clandestinely manufactured, methcathinone is almost exclusively sold in the stable and highly water soluble hydrochloride salt form. It is most commonly snorted, although it can be taken orally by mixing it with a beverage or diluted in water and injected intravenously.
Methcathinone has an abuse potential equivalent to methamphetamine, and produces amphetamine-like activity including superabundant energy, hyperactivity, extended wakefulness and loss of appetite. Pleasant effects include a burst of energy, speeding of the mind, increased feelings of invincibility and euphoria. Unpleasant effects include anxiety, tremor, insomnia, weight loss, dehydration, sweating, stomach pains, pounding heart, nose bleeds and body aches. Toxic levels may produce convulsions, paranoia, and hallucinations. Like other CNS stimulants, binges are usually followed by a "crash" with periods of variable depression.
Travel back to the DRCNet Response to the DEA Home Page
Travel back to the List of DEA Publications
Travel back to the Drugs of Abuse Table of Contents
Travel back to the Drugs of Abuse StimulantsChapter